Having trouble accessing articles? Reset your cache.

RLY5016: Phase IIb data

The double-blind, international Phase IIb PEARL-HF trial in 104 patients already receiving >=1 renin-angiotensin-aldosterone system (RAAS)

Read the full 169 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE